NCT03029715

Brief Summary

Background: Laparoscopic sleeve gastrectomy is commonly done with total intravenous anaesthesia (TIVA) or balanced anaesthesia using intravenous and an inhalation agent. It is still unclear which anaesthesia regimen is better for this group of patients. The present study was carried out to compare the use of inhalation anaesthesia technique using desflurane and TIVA using propofol and dexmedetomidine. Methods: This randomized controlled trial was carried out on 100 morbidly obese patients undergoing laparoscopic sleeve gastrectomy. The patients were randomized into two equal groups, inhalational group and TIVA group for anaesthesia maintenance. All patients received general anaesthesia and induced with propofol, remifentanil and cis-atracurium. In inhalation group, anaesthesia was maintained by desflurane in oxygen air mixture while in TIVA group anaesthesia was maintained by intravenous propofol and dexmedetomidine infusion. Intra-operative vital signs and anaesthesia recovery time were recorded. Post-operative nausea, vomiting, pain score, analgesic consumption, the onset of bowel movement, and post-anaesthetic care unit (PACU) stay were studied for both groups.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2014

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2014

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 14, 2017

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 24, 2017

Completed
3.6 years until next milestone

Results Posted

Study results publicly available

September 16, 2020

Completed
Last Updated

September 16, 2020

Status Verified

August 1, 2020

Enrollment Period

2.1 years

First QC Date

January 14, 2017

Results QC Date

August 10, 2020

Last Update Submit

August 26, 2020

Conditions

Keywords

Sleeve gastrectomyTIVA

Outcome Measures

Primary Outcomes (1)

  • Analgesic Requirements.

    Total paracetamol consumption.

    Within one hour after surgery

Secondary Outcomes (1)

  • The Intra-operative Mean Arterial Blood Pressure.

    During operation and follow-up, an average of 2 hours

Study Arms (2)

Intravenous anaesthesia

OTHER

Propofol Dexmedetomidine Remifentanil

Drug: PropofolDrug: RemifentanilDrug: Dexmedetomidine

Inhalation anaesthesia

OTHER

Desflurane Remifentanil

Drug: RemifentanilDrug: Desflurane

Interventions

Total intravenous anaesthesia.

Also known as: TIVA group
Intravenous anaesthesia

Narcotics

Also known as: TIVA group and inhalation group
Inhalation anaesthesiaIntravenous anaesthesia

Total intravenous anaesthesia

Also known as: TIVA group
Intravenous anaesthesia

Inhalation anaesthesia.

Also known as: Inhalation group
Inhalation anaesthesia

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Morbid obese scheduled for sleeve gastrectomy.

You may not qualify if:

  • Patients refusal and allergy to drugs used.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Elbakry AE, Sultan WE, Ibrahim E. A comparison between inhalational (Desflurane) and total intravenous anaesthesia (Propofol and dexmedetomidine) in improving postoperative recovery for morbidly obese patients undergoing laparoscopic sleeve gastrectomy: A double-blinded randomised controlled trial. J Clin Anesth. 2018 Mar;45:6-11. doi: 10.1016/j.jclinane.2017.12.001. Epub 2017 Dec 8.

MeSH Terms

Conditions

Obesity

Interventions

PropofolRemifentanilDexmedetomidineDesflurane

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsPropionatesAcids, AcyclicCarboxylic AcidsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsImidazolesAzolesEthyl EthersEthersMethyl EthersHydrocarbons, FluorinatedHydrocarbons, Halogenated

Results Point of Contact

Title
Dr Ezzeldin Ibrahim
Organization
Menoufia Univeristy

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor in anaesthesia, intensive care, and pain medicine.

Study Record Dates

First Submitted

January 14, 2017

First Posted

January 24, 2017

Study Start

February 1, 2014

Primary Completion

March 1, 2016

Study Completion

September 1, 2016

Last Updated

September 16, 2020

Results First Posted

September 16, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share